Advancements in protein glycosylation biomarkers for ovarian cancer through mass spectrometry-based approaches

References

• Ozols RF, Bookman MA, Connolly DC, et al. Focus on epithelial ovarian cancer. Cancer Cell. 2004 Jan;5(1):19–24.
   PubMed Web of Science ®Google Scholar
• Quesada S, Thomas QD, Colombo PE, et al. Optimal first-line medico-surgical strategy in ovarian cancers: are we there yet? Cancers (Basel). 2023 Jul 10;15(14):3556. doi: 10.3390/cancers15143556
   PubMed Web of Science ®Google Scholar
• Miller DS, Blessing JA, Krasner CN, et al. Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the gynecologic oncology group. J Clin Oncol. 2009 Jun 1;27(16):2686–2691. doi: 10.1200/JCO.2008.19.2963
   PubMed Web of Science ®Google Scholar
• Xu S, Yue Y, Zhang S, et al. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway. J Exp Clin Cancer Res. 2018 Dec 5;37(1):305. doi: 10.1186/s13046-018-0977-y
   PubMedGoogle Scholar
• Shen X, Wang C, Zhu H, et al. Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells. J Ovarian Res. 2021 Feb 24;14(1):38. doi: 10.1186/s13048-021-00776-2
   PubMed Web of Science ®Google Scholar
• Zhou W, Ma J, Zhao H, et al. Serum exosomes from epithelial ovarian cancer patients contain LRP1, which promotes the migration of epithelial ovarian cancer cell. Mol Cell Proteomics. 2023 Apr;22(4):100520.
   PubMed Web of Science ®Google Scholar
• Li B, An HJ, Kirmiz C, et al. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. J Proteome Res. 2008;7(9):3776–3788. doi: 10.1021/pr800297u
   PubMed Web of Science ®Google Scholar
• Wu J, Xie X, Liu Y, et al. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. J Proteome Res. 2012 Sep 7;11(9):4541–4552. doi: 10.1021/pr300330z
   PubMed Web of Science ®Google Scholar
• Andersen JD, Boylan KL, Jemmerson R, et al. Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients. J Ovarian Res. 2010 Sep 10;3(1):21. doi: 10.1186/1757-2215-3-21
   PubMedGoogle Scholar
• Wu J, Xie X, Nie S, et al. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis. J Proteome Res. 2013 Jul 5;12(7):3342–3352. doi: 10.1021/pr400169n
   PubMed Web of Science ®Google Scholar
• Hu Y, Pan J, Shah P, et al. Integrated proteomic and glycoproteomic characterization of human high-grade serous ovarian carcinoma. Cell Rep. 2020 Oct 20;33(3):108276. doi: 10.1016/j.celrep.2020.108276
   PubMed Web of Science ®Google Scholar
• Boylan KLM, Afiuni-Zadeh S, Geller MA, et al. Evaluation of the potential of pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics. Clin Proteomics. 2021 Jan 7;18(1):4. doi: 10.1186/s12014-020-09309-3
   PubMed Web of Science ®Google Scholar
• Cortesi L, Rossi E, Della Casa L, et al. Protein expression patterns associated with advanced stage ovarian cancer. Electrophoresis. 2011 Aug;32(15):1992–2003.
   PubMed Web of Science ®Google Scholar
• Maxwell GL, Hood BL, Day R, et al. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation. Gynecol Oncol. 2011 Jun 1;121(3):586–594. doi: 10.1016/j.ygyno.2011.02.031
   PubMed Web of Science ®Google Scholar
• Steitz AM, Steffes A, Finkernagel F, et al. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis. 2020 Apr 20;11(4):249. doi: 10.1038/s41419-020-2438-8
   PubMed Web of Science ®Google Scholar
• Kuzmanov U, Musrap N, Kosanam H, et al. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids. Clin Chem Lab Med. 2013 Jul;51(7):1467–1476.
   PubMed Web of Science ®Google Scholar
• Song G, Chen L, Zhang B, et al. Proteome-wide tyrosine phosphorylation analysis reveals dysregulated signaling pathways in ovarian tumors. Mol Cell Proteomics. 2019 Mar;18(3):448–460.
   PubMed Web of Science ®Google Scholar
• Jakobsson ME, Moen A, Davidson B, et al. Hsp70 (HSPA1) lysine methylation status as a potential prognostic factor in metastatic high-grade serous carcinoma. PLoS One. 2015;10(10):e0140168. doi: 10.1371/journal.pone.0140168
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Xia K, Yang X, et al. Alternative splicing acts as an independent prognosticator in ovarian carcinoma. Sci Rep. 2021 May 17;11(1):10413. doi: 10.1038/s41598-021-89778-0
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Y, Qian Y, et al. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics. PLoS One. 2014;9(2):e87978. doi: 10.1371/journal.pone.0087978
   PubMed Web of Science ®Google Scholar
• Chen H, Deng Z, Huang C, et al. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Tumor Biol. 2017;39(7):1010428317716249. doi: 10.1177/1010428317716249
   Google Scholar
• Biskup K, Braicu EI, Sehouli J, et al. The ascites N-glycome of epithelial ovarian cancer patients. J Proteomics. 2017;157:33–39. doi: 10.1016/j.jprot.2017.02.001
   PubMed Web of Science ®Google Scholar
• Cheng M, Shu H, Peng Y, et al. Specific analysis of α-2, 3-sialylated N-Glycan linkage isomers by microchip capillary electrophoresis–mass spectrometry. Anal Chem. 2021;93(13):5537–5546. doi: 10.1021/acs.analchem.1c00064
   PubMed Web of Science ®Google Scholar
• Ricardo S, Marcos-Silva L, Pereira D, et al. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours. Mol Oncol. 2015;9(2):503–512. doi: 10.1016/j.molonc.2014.10.005
   PubMed Web of Science ®Google Scholar
• Coelho R, Marcos-Silva L, Mendes N, et al. Mucins and truncated O-glycans unveil phenotypic discrepancies between serous ovarian cancer cell lines and primary tumours. Int J Mol Sci. 2018;19(7):2045. doi: 10.3390/ijms19072045
   PubMed Web of Science ®Google Scholar
• Ferraro S, Braga F, Lanzoni M, et al. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol. 2013;66(4):273–281. doi: 10.1136/jclinpath-2012-201031
   PubMed Web of Science ®Google Scholar
• Armbrister R, Ochoa L, Abbott KL. The clinical role of glycobiology on ovarian cancer progression. In: Abbott KL, Dimitroff C, editors. Advances in cancer research. Vol. 157. Amsterdam, The Netherlands: Elsevier; 2023. p. 1–22.
   Google Scholar
• Vitiazeva V, Kattla JJ, Flowers SA, et al. The O-linked glycome and blood group antigens ABO on mucin-type glycoproteins in mucinous and serous epithelial ovarian tumors. PLoS One. 2015;10(6):e0130197. doi: 10.1371/journal.pone.0130197
   PubMed Web of Science ®Google Scholar
• Saldova R, Struwe WB, Wynne K, et al. Exploring the glycosylation of serum CA125. Int J Mol Sci. 2013;14(8):15636–15654. doi: 10.3390/ijms140815636
   PubMed Web of Science ®Google Scholar
• Biskup K, Braicu EI, Sehouli J, et al. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer. J Proteome Res. 2013;12(9):4056–4063. doi: 10.1021/pr400405x
   PubMed Web of Science ®Google Scholar
• Biskup K, Braicu EI, Sehouli J, et al. The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases. Dis Markers. 2014;2014:1–10. doi: 10.1155/2014/238197
   Web of Science ®Google Scholar
• Kim J-H, Park CW, Um D, et al. Mass spectrometric screening of ovarian cancer with serum glycans. Dis Markers. 2014;2014:1–9. doi: 10.1155/2014/634289
   Web of Science ®Google Scholar
• Anugraham M, Jacob F, Nixdorf S, et al. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status. Mol Cell Proteomics. 2014;13(9):2213–2232. doi: 10.1074/mcp.M113.037085
   PubMed Web of Science ®Google Scholar
• Drake RR, Powers TW, Jones EE, et al. MALDI mass spectrometry imaging of N-linked glycans in cancer tissues. Adv Cancer Res. 2017;134:85–116.
   PubMed Web of Science ®Google Scholar
• Briggs MT, Condina MR, Ho YY, et al. MALDI mass spectrometry imaging of early‐and late‐stage serous ovarian cancer tissue reveals stage‐specific N‐glycans. Proteomics. 2019;19(21–22):1800482. doi: 10.1002/pmic.201800482
   PubMed Web of Science ®Google Scholar
• Grzeski M, Taube ET, Braicu EI, et al. In situ N-glycosylation signatures of epithelial ovarian cancer tissue as defined by MALDI mass spectrometry imaging. Cancers. 2022;14(4):1021. doi: 10.3390/cancers14041021
   PubMed Web of Science ®Google Scholar
• Kim K, Ruhaak LR, Nguyen UT, et al. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(4):611–621. doi: 10.1158/1055-9965.EPI-13-1073
   PubMed Web of Science ®Google Scholar
• Alley WR Jr., Vasseur JA, Goetz JA, et al. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res. 2012 Apr 6;11(4):2282–2300. doi: 10.1021/pr201070k
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Kim K, Stroble C, et al. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients. J Proteome Res. 2016 Mar 4;15(3):1002–1010. doi: 10.1021/acs.jproteome.5b01071
   PubMed Web of Science ®Google Scholar
• Wieczorek M, Braicu EI, Oliveira-Ferrer L, et al. Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer. Front Immunol. 2020;11:654. doi: 10.3389/fimmu.2020.00654
   PubMed Web of Science ®Google Scholar
• O’Flaherty R, Muniyappa M, Walsh I, et al. A robust and versatile automated glycoanalytical technology for serum antibodies and acute phase proteins: ovarian cancer Case Study. Mol Cell Proteomics. 2019 Nov;18(11):2191–2206.
   PubMed Web of Science ®Google Scholar
• Escrevente C, Machado E, Brito C, et al. Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Int J Oncol. 2006 Sep;29(3):557–566.
   PubMed Web of Science ®Google Scholar
• Akita K, Yoshida S, Ikehara Y, et al. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer. Int J Gynecol Cancer. 2012 May;22(4):531–538.
   PubMed Web of Science ®Google Scholar
• Gubbels JA, Belisle J, Onda M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer. 2006 Oct 26;5(1):50. doi: 10.1186/1476-4598-5-50
   PubMed Web of Science ®Google Scholar
• Newsom-Davis TE, Wang D, Steinman L, et al. Enhanced immune recognition of cryptic glycan markers in human tumors. Cancer Res. 2009 Mar 1;69(5):2018–2025. doi: 10.1158/0008-5472.CAN-08-3589
   PubMed Web of Science ®Google Scholar
• Scholler N, Crawford M, Sato A, et al. Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2117–2124. doi: 10.1158/1078-0432.CCR-05-2007
   PubMed Web of Science ®Google Scholar
• Shetty V, Hafner J, Shah P, et al. Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics. Clin Proteomics. 2012 Aug 2;9(1):10. doi: 10.1186/1559-0275-9-10
   PubMedGoogle Scholar
• Wang PH, Lee WL, Juang CM, et al. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol. 2005 Dec;99(3):631–639.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Yamamoto E, Ino K, et al. High expression of N-acetylglucosaminyltransferase V in mucinous tumors of the ovary. Oncol Rep. 2009 Nov;22(5):1027–1032.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ikeda Y, Miyoshi E, et al. alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer. 2000 Dec 15;88(6):914–919. doi: 10.1002/1097-0215(20001215)88:6<914:AID-IJC12>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Allam H, Aoki K, Benigno BB, et al. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions. J Proteome Res. 2015;14(1):434–446. doi: 10.1021/pr501174p
   PubMed Web of Science ®Google Scholar
• Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006 Sep 8;126(5):855–867. doi: 10.1016/j.cell.2006.08.019
   PubMed Web of Science ®Google Scholar
• Rye CS, Withers SG. Glycosidase mechanisms. Curr Opin Chem Biol. 2000 Oct;4(5):573–580. doi: 10.1016/S1367-5931(00)00135-6
   PubMed Web of Science ®Google Scholar
• Varki A. Biological roles of glycans. Glycobiology. 2017 Jan;27(1):3–49. doi: 10.1093/glycob/cww086
   PubMed Web of Science ®Google Scholar
• Hasan MM, Mimi MA, Mamun MA, et al. Mass spectrometry imaging for glycome in the brain. Front Neuroanat. 2021;15:711955. doi: 10.3389/fnana.2021.711955
   PubMed Web of Science ®Google Scholar
• Mitra I, Alley WR Jr., Goetz JA, et al. Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis. J Proteome Res. 2013 Oct 4;12(10):4490–4496. doi: 10.1021/pr400549e
   PubMed Web of Science ®Google Scholar
• Vreeker GC, Nicolardi S, Madunic K, et al. O-and N-glycosylation analysis of cell lines by ultrahigh resolution MALDI-FTICR-MS. Int J Mass Spectrom. 2020;448:116267. doi: 10.1016/j.ijms.2019.116267
   Web of Science ®Google Scholar
• Vreeker GC, Nicolardi S, Bladergroen MR, et al. Automated plasma glycomics with linkage-specific sialic acid esterification and ultrahigh resolution MS. Anal Chem. 2018;90(20):11955–11961. doi: 10.1021/acs.analchem.8b02391
   PubMed Web of Science ®Google Scholar
• Heijs B, Potthoff A, Soltwisch J, et al. MALDI-2 for the enhanced analysis of N-linked glycans by mass spectrometry imaging. Anal Chem. 2020;92(20):13904–13911. doi: 10.1021/acs.analchem.0c02732
   PubMed Web of Science ®Google Scholar
• Everest-Dass AV, Briggs MT, Kaur G, et al. N-glycan MALDI imaging mass spectrometry on formalin-fixed paraffin-embedded tissue enables the delineation of ovarian cancer tissues. Mol & Cell Proteomics. 2016;15(9):3003–3016. doi: 10.1074/mcp.M116.059816
   PubMed Web of Science ®Google Scholar
• An HJ, Miyamoto S, Lancaster KS, et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res. 2006 Jul;5(7):1626–1635.
   PubMed Web of Science ®Google Scholar
• Dědová T, Braicu EI, Sehouli J, et al. Sialic acid linkage analysis refines the diagnosis of ovarian cancer. Front Oncol. 2019;9:261. doi: 10.3389/fonc.2019.00261
   PubMed Web of Science ®Google Scholar
• Hua S, Williams CC, Dimapasoc LM, et al. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A. 2013;1279:58–67. doi: 10.1016/j.chroma.2012.12.079
   PubMed Web of Science ®Google Scholar
• Mechref Y, Hu Y, Garcia A, et al. Defining putative glycan cancer biomarkers by MS. Bioanalysis. 2012 Oct;4(20):2457–2469.
   PubMed Web of Science ®Google Scholar
• Anugraham M, Jacob F, Everest‐Dass AV, et al. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. Mol Oncol. 2017;11(11):1595–1615. doi: 10.1002/1878-0261.12134
   PubMed Web of Science ®Google Scholar
• Briggs MT, Condina MR, Klingler-Hoffmann M, et al. Translating N-Glycan analytical applications into clinical strategies for ovarian cancer. Proteomics Clin Appl. 2019 May;13(3):e1800099.
   PubMed Web of Science ®Google Scholar
• Wanyama FM, Blanchard V. Glycomic-based biomarkers for ovarian cancer: advances and challenges. Diagnostics. 2021 Apr 1;11(4):643. doi: 10.3390/diagnostics11040643
   Web of Science ®Google Scholar
• Machado E, Kandzia S, Carilho R, et al. N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Glycobiology. 2011;21(3):376–386. doi: 10.1093/glycob/cwq170
   PubMed Web of Science ®Google Scholar
• Saldova R, Royle L, Radcliffe CM, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 2007;17(12):1344–1356. doi: 10.1093/glycob/cwm100
   PubMed Web of Science ®Google Scholar
• Thomsson KA, Vitiazeva V, Mateoiu C, et al. Sulfation of O-glycans on mucin-type proteins from serous ovarian epithelial tumors. Mol Cell Proteomics. 2021;20:20. doi: 10.1016/j.mcpro.2021.100150
   Web of Science ®Google Scholar
• Karlsson NG, McGuckin MA. O-Linked glycome and proteome of high-molecular-mass proteins in human ovarian cancer ascites: identification of sulfation, disialic acid and O-linked fucose. Glycobiology. 2012;22(7):918–929. doi: 10.1093/glycob/cws060
   PubMed Web of Science ®Google Scholar
• Hua S, An HJ. Glycoscience aids in biomarker discovery. BMB Rep. 2012;45(6):323–330. doi: 10.5483/BMBRep.2012.45.6.132
   PubMed Web of Science ®Google Scholar
• Li K, Pei Y, Wu Y, et al. Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis. J Ovarian Res. 2020;13(1):6. doi: 10.1186/s13048-019-0605-2
   PubMed Web of Science ®Google Scholar
• Zhao R, Lin G, Wang Y, et al. Use of the serum glycan state to predict ovarian cancer patients’ clinical response to chemotherapy treatment. J Proteomics. 2020;223:103752. doi: 10.1016/j.jprot.2020.103752
   PubMed Web of Science ®Google Scholar
• Zahradnikova M, Ihnatova I, Lattova E, et al. N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer. J Proteomics. 2021;230:103964. doi: 10.1016/j.jprot.2020.103964
   PubMed Web of Science ®Google Scholar
• Dall’olio F, Malagolini N, Trinchera M, et al. Mechanisms of cancer-associated glycosylation changes. Front Biosci. 2012;17(1):670. doi: 10.2741/3951
   Google Scholar
• Young C, Condina MR, Briggs MT, et al. In-house packed porous graphitic carbon columns for liquid chromatography-mass spectrometry analysis of N-Glycans. Front Chem. 2021;9:653959. doi: 10.3389/fchem.2021.653959
   PubMed Web of Science ®Google Scholar
• Chen K, Gentry-Maharaj A, Burnell M, et al. Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J Proteome Res. 2013 Mar 1;12(3):1408–1418. doi: 10.1021/pr3010474
   PubMed Web of Science ®Google Scholar
• Veillon L, Huang Y, Peng W, et al. Characterization of isomeric glycan structures by LC‐MS/MS. Electrophoresis. 2017;38(17):2100–2114. doi: 10.1002/elps.201700042
   PubMed Web of Science ®Google Scholar
• Hua S, Nwosu CC, Strum JS, et al. Site-specific protein glycosylation analysis with glycan isomer differentiation. Anal Bioanal Chem. 2012;403(5):1291–1302. doi: 10.1007/s00216-011-5109-x
   PubMed Web of Science ®Google Scholar
• Seo N, Lee H, Oh MJ, et al. Isomer-specific monitoring of sialylated N-Glycans reveals association of α2, 3-linked sialic acid epitope with Behcet’s disease. Front Mol Biosci. 2021;8:778851. doi: 10.3389/fmolb.2021.778851
   PubMed Web of Science ®Google Scholar
• Hua S, Jeong HN, Dimapasoc LM, et al. Isomer-specific LC/MS and LC/MS/MS profiling of the mouse serum N-glycome revealing a number of novel sialylated N-glycans. Anal Chem. 2013;85(9):4636–4643. doi: 10.1021/ac400195h
   PubMed Web of Science ®Google Scholar
• Lee J, Ha S, Kim M, et al. Spatial and temporal diversity of glycome expression in mammalian brain. Proc Natl Acad Sci U S A. 2020;117(46):28743–28753. doi: 10.1073/pnas.2014207117
   PubMed Web of Science ®Google Scholar
• Hua S, An HJ, Ozcan S, et al. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst. 2011;136(18):3663–3671. doi: 10.1039/c1an15093f
   PubMed Web of Science ®Google Scholar
• Harvey DJ, Crispin M, Scanlan C, et al. Differentiation between isomeric triantennary N‐linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (β1‐4‐GlcNAc) residue in N‐glycans from IgG. Rapid Commun Mass Spectrom. 2008;22(7):1047–1052. doi: 10.1002/rcm.3470
   PubMed Web of Science ®Google Scholar
• Saldova R, Piccard H, Pérez-Garay M, et al. Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression. PLoS One. 2013;8(8):e71159. doi: 10.1371/journal.pone.0071159
   PubMed Web of Science ®Google Scholar
• Hoadley KA, Yau C, Hinoue T, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018 Apr 5;173(2):291–304 e6. doi: 10.1016/j.cell.2018.03.022
   PubMed Web of Science ®Google Scholar
• Iwahashi N, Inai Y, Minakata S, et al. C-Mannosyl tryptophan increases in the plasma of patients with ovarian cancer. Oncol Lett. 2020 Jan;19(1):908–916.
   PubMed Web of Science ®Google Scholar
• Minakata S, Manabe S, Inai Y, et al. Protein C-Mannosylation and C-Mannosyl Tryptophan in chemical biology and medicine. Molecules. 2021 Aug 30;26(17):5258. doi: 10.3390/molecules26175258
   PubMed Web of Science ®Google Scholar
• Morishita S, Suzuki T, Niwa Y, et al. Dpy-19 like 3-mediated C-mannosylation and expression levels of RPE-spondin in human tumor cell lines. Oncol Lett. 2017 Aug;14(2):2537–2544.
   PubMed Web of Science ®Google Scholar
• Sakurai S, Inai Y, Minakata S, et al. A novel assay for detection and quantification of C-mannosyl tryptophan in normal or diabetic mice. Sci Rep. 2019 Mar 18;9(1):4675. doi: 10.1038/s41598-019-41278-y
   PubMedGoogle Scholar
• Minakata S, Inai Y, Manabe S, et al. Monomeric C-mannosyl tryptophan is a degradation product of autophagy in cultured cells. Glycoconj J. 2020 Oct;37(5):635–645.
   PubMed Web of Science ®Google Scholar
• Bereman MS, Williams TI, Muddiman DC. Carbohydrate analysis by desorption electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem. 2007;79(22):8812–8815. doi: 10.1021/ac0713858
   PubMed Web of Science ®Google Scholar
• Škrášková K, Claude E, Jones EA, et al. Enhanced capabilities for imaging gangliosides in murine brain with matrix-assisted laser desorption/ionization and desorption electrospray ionization mass spectrometry coupled to ion mobility separation. Methods. 2016;104:69–78. doi: 10.1016/j.ymeth.2016.02.014
   PubMed Web of Science ®Google Scholar
• Pace CL, Muddiman DC. Direct analysis of native N-linked glycans by IR-MALDESI. J Am Soc. 2020;31(8):1759–1762. doi: 10.1021/jasms.0c00176
   Google Scholar
• Angerer TB, Bour J, Biagi JL, et al. Evaluation of 6 MALDI-Matrices for 10 mum lipid imaging and on-tissue MSn with AP-MALDI-Orbitrap. J Am Soc Mass Spectrom. 2022 May 4;33(5):760–771. doi: 10.1021/jasms.1c00327
   PubMed Web of Science ®Google Scholar
• Sampson JS, Hawkridge AM, Muddiman DC, et al. Generation and detection of multiply-charged peptides and proteins by matrix-assisted laser desorption electrospray ionization (MALDESI) Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom. 2006;17(12):1712–1716. doi: 10.1016/j.jasms.2006.08.003
   PubMed Web of Science ®Google Scholar
• Nazari M, Muddiman DC. MALDESI: Fundamentals, direct analysis, and MS imaging. Advances In MALDI And Laser-Induced Soft Ionization Mass Spectrometry. 2016;169–182.
   Google Scholar
• Wilkinson H, Saldova R. Current methods for the characterization of O-glycans. J Proteome Res. 2020;19(10):3890–3905. doi: 10.1021/acs.jproteome.0c00435
   PubMed Web of Science ®Google Scholar
• Goso Y, Tsubokawa D, Ishihara K. Evaluation of conditions for release of mucin-type oligosaccharides from glycoproteins by hydrazine gas treatment. J Biochem. 2009;145(6):739–749. doi: 10.1093/jb/mvp031
   PubMed Web of Science ®Google Scholar
• Malaker SA, Pedram K, Ferracane MJ, et al. The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins. Proc Natl Acad Sci U S A. 2019;116(15):7278–7287. doi: 10.1073/pnas.1813020116
   PubMed Web of Science ®Google Scholar
• Chirag Dhar PR, Gege X, Pickering C, et al. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling. medRxiv. 2023.
   Google Scholar